CoVLP (brand name Covifenz) was a COVID-19 vaccine developed by Medicago in Canada and GlaxoSmithKline (GSK). The product and Medicago, Inc. were owned...

Emergency (2) Belarus Cuba Travel-only Guyana Malaysia New Zealand Turkey CoVLP is a virus-like particle vaccine grown in an Australian weed, Nicotiana...

associated illnesses. The lead COVID-19 vaccine candidate, CoVLP, by Medicago, was a coronavirus VLP grown in the Australian weed, Nicotiana benthamiana. Medicago...

Virus-like particles (VLPs) are molecules that closely resemble viruses, but are non-infectious because they contain no viral genetic material. They can...

February 2022, Health Canada authorised use of the COVID-19 vaccine called CoVLP (brand name Covifenz) developed from N. benthamiana for preventing infection...

acquired immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID‑19). Prior to the...

Soberana 02, Soberana Plus, V-01, and ZF2001. one virus-like particle vaccine: CoVLP As of June 2022[update], 353 vaccine candidates are in various stages of...

(COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The first case in Nepal was confirmed on 23 January 2020 when a 31-year-old...

receptor binding domain of the SARS-CoV-2 spike protein to invoke an immune response in mice. A stable AP205 VLP was designed by using a linker to fuse...

Pakse International Airport (IATA: PKZ, ICAO: VLPS) is one of the few international airports in Laos. Pakse is the former southern capital city of the...